title: Risk of breast and prostate cancer is not associated with increased homozygosity in outbred populations.
abstract: Regions of restricted genetic heterogeneity due to identity by descent (autozygosity) are known to confer susceptibility to a number of diseases. Regions of germline homozygosity (ROHs) of 1-2 Mb, the result of autozygosity, are detectable at high frequency in outbred populations. Recent studies have reported that ROHs, possibly through exposing recessive disease-causing alleles or alternative mechanisms, are associated with an increased cancer risk. To examine whether homozygosity is associated with breast or prostate cancer risk, we analysed 500K single-nucleotide polymorphism data from two genome-wide association studies conducted by the Cancer Genetics Markers of Susceptibility initiatives (http://cgems.cancer.gov/). Six common ROHs were associated with breast cancer risk and four with prostate cancer (P<0.01). Intriguingly, one of the breast cancer ROHs maps to 6q22.31-6q22.3, a region that has been previously shown to confer breast cancer risk. Although none of the ROHs remained significantly associated with cancer risk after adjustment for multiple testing, a number of ROHs merit further interrogation. However, our findings provide no strong evidence that levels of measured homozygosity, whatever their aetiology (autozygosity, uniparental isodisomy or hemizygosity), confer an increased risk of developing breast or prostate cancer in predominantly outbred populations.
authors.affiliation: Section of Cancer Genetics, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey, UK.
authors.forename: Victor
authors.initials: V
authors.lastname: Enciso-Mora
authors.forename: Fay J
authors.initials: FJ
authors.lastname: Hosking
authors.forename: Richard S
authors.initials: RS
authors.lastname: Houlston
mesh_terms: D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics*; D016022:Case-Control Studies; D005260:Female; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D055106:Genome-Wide Association Study; D006720:Homozygote; D006801:Humans; D008297:Male; D020641:Polymorphism, Single Nucleotide; D011471:Prostatic Neoplasms / Q000453:epidemiology / Q000235:genetics*; D012306:Risk
chemical_list: D005819:Genetic Markers
references.citation: Asian Pac J Cancer Prev. 2009 Jan-Mar;10(1):35-40
references.pmid: 19469621
references.citation: JAMA. 2008 Mar 26;299(12):1437-45
references.pmid: 18364486
references.citation: PLoS Biol. 2006 Mar;4(3):e72
references.pmid: 16494531
references.citation: Nature. 2005 Oct 27;437(7063):1299-320
references.pmid: 16255080
references.citation: PLoS Genet. 2007 Jun;3(6):e90
references.pmid: 17542651
references.citation: Hum Mol Genet. 2008 Oct 15;17(R2):R109-15
references.pmid: 18852198
references.citation: Nat Rev Genet. 2003 Sep;4(9):721-34
references.pmid: 12951573
references.citation: Am J Hum Genet. 1999 Dec;65(6):1493-500
references.pmid: 10577902
references.citation: Hum Mutat. 2006 Nov;27(11):1115-21
references.pmid: 16955415
references.citation: DNA Cell Biol. 2006 Mar;25(3):135-41
references.pmid: 16569192
references.citation: Am J Med Genet. 1989 May;33(1):1-6
references.pmid: 2750776
references.citation: Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):135-40
references.pmid: 16371466
references.citation: J Natl Cancer Inst. 1978 Aug;61(2):307-14
references.pmid: 277717
references.citation: Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4340-5
references.pmid: 18326623
references.citation: Cancer Res. 2008 Apr 15;68(8):2610-21
references.pmid: 18375840
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):19942-7
references.pmid: 18077426
references.citation: Lancet. 1991 Oct 12;338(8772):954
references.pmid: 1681304
references.citation: Hum Mol Genet. 2006 Mar 1;15(5):789-95
references.pmid: 16436455
references.citation: Nat Rev Genet. 2009 Sep;10(9):639-50
references.pmid: 19687804
references.citation: Blood. 2007 Apr 15;109(8):3451-61
references.pmid: 17170124
references.citation: Nature. 1991 Jun 20;351(6328):665-7
references.pmid: 1675767
references.citation: Hum Mol Genet. 2007 Jan 1;16(1):1-14
references.pmid: 17116639
references.citation: N Engl J Med. 2000 Jul 13;343(2):78-85
references.pmid: 10891514
references.citation: Nat Genet. 2003 Mar;33 Suppl:238-44
references.pmid: 12610533
references.citation: Nat Genet. 2007 May;39(5):645-9
references.pmid: 17401363
references.citation: Nature. 2007 Jun 28;447(7148):1087-93
references.pmid: 17529967
references.citation: Cancer. 1976 Dec;38(6):2548-50
references.pmid: 1069604
references.citation: Nat Genet. 2007 Jul;39(7):870-4
references.pmid: 17529973
references.citation: Nat Genet. 2008 Mar;40(3):316-21
references.pmid: 18264097
references.citation: Am J Hum Genet. 2007 Sep;81(3):559-75
references.pmid: 17701901
references.citation: Am J Obstet Gynecol. 1981 Nov 15;141(6):629-36
references.pmid: 7315892
references.citation: Genetics. 1989 Nov;123(3):585-95
references.pmid: 2513255
references.citation: Am J Hum Genet. 2006 May;78(5):889-896
references.pmid: 16642444
references.citation: Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12216-21
references.pmid: 11050243